‹ All Posts
Chahat Aggrawal

20th Mar · SEBI-Registered Analyst

Natco Pharma Launches Affordable Generic Semaglutide in India

💉

NATCOPHARM
has launched India’s first generic semaglutide injection in multi-dose vial format, priced at ₹1,290, offering ~70% savings compared to pen devices and ~90% lower pricing versus the original brand, significantly improving affordability and accessibility for patients in the domestic market.

#FundamentalViews#WatchOutFor
1,179 likes·61 comments